CNF
Cochrane Neurosciences Field


released: 1 February 2015
last updated: 1 February 2015



How this list was created:

In 2014 the Cochrane Neurosciences Field (CNF) searched the list of recommendations published in Choosing Wisely for those of interest from a neurological point of view, dealing with transient loss of consciousness. Two recommendations have been included in the present list (number 4 adapted from the American Academy of Neurology and number 5 adapted from the American College of Physicians) but the term transient loss of consciousness has been preferred to the original syncope because the first means the symptom to be evaluated and the second the conclusion of a diagnostic process. Transient loss of consciousness is intended as in NICE 2010: “transient loss of consciousness is the medical term for a blackout and can be defined as spontaneous loss of consciousness with complete recovery (full recovery of consciousness without any residual neurological deficit)”. Other three recommendations in this list are original, identified in the Italian medical practice (1, 2 and 3) and discussed in the CNF with the contribution of other clinicians on the behalf of AINAT, Italian Association of Out-Patient Department Neurologists


released: 1 March 2014
last updated: 1 February 2015



How this list was created:

In November 2013 the Cochrane Neurosciences Field (CNF) searched the list of recommendations published in Choosing Wisely for those of interest from a neurological point of view, dealing with dementia. The first three recommendations of present list are adapted from Choosing Wisely Master List (American Academy of Hospice and Palliative Medicine, American Geriatrics Society, AMDA – Dedicated to Long Term Care Medicine™, American Psychiatric Association) and were found to be adequate for the Italian situation. The fourth recommendation, initially inspired to the corresponding one by the Society of Nuclear Medicine and Molecular Imaging, has been radically amended and updated in January 2015. The last recommendation arises from the need to identify the correct use of diagnostic imaging, recently introduced in cognitive impairment, warning of the risk of over-diagnosis. The last two recommendations will be given particular attention in future updates.

About this society:

The Cochrane Neurosciences Field (CNF) is an entity of the Cochrane Collaboration; It was formally registered in 2000. Headquarters were in Milan, at the University Department of Neurological Sciences, until 2006, since 2007 it has been based in Perugia at the Region Umbria Health Authority. The main objective of the CNF is to disseminate Cochrane reviews of neurological interest, promoting evidence-based medicine, building links between review authors, clinicians, patients, their families and administrators to contribute to the health information of citizens and provide scientific support to health professionals and decision makers. The team is made up of the director of the field, the coordinator, clinical neurologists, administrative staff, and archive management. http://neuronet.cochrane.org/.